APO Research
Talk to an analyst

APO RESEARCH · REPORT

Absorbable Hemostatic Materials

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Absorbable Hemostatic Materials Market Outlook and Growth Opportunities 2026

19 December 2025199 pages

Choose your research edition.

Industry ResearchAbsorbable Hemostatic Materials Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Absorbable Hemostatic Materials Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Absorbable Hemostatic Materials Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Absorbable Hemostatic Materials Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Absorbable Hemostatic Materials Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Absorbable Hemostatic Materials market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Absorbable Hemostatic Materials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Absorbable Hemostatic Materials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Absorbable Hemostatic Materials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Absorbable Hemostatic Materials market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Absorbable Hemostatic Materials market include Johnson & Johnson, Guizhou Jin Jiu Biotech, B.Braun, Beijing Taikesiman, Beijing Datsing Bio-tech, Baxter, Zhonghui Shengxi, Saikesaisi Holdings Group and Meril Life Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Absorbable Hemostatic Materials market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Absorbable Hemostatic Materials and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Absorbable Hemostatic Materials revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Absorbable Hemostatic Materials market.

Absorbable Hemostatic Materials Segment by Company

Johnson & Johnson

Guizhou Jin Jiu Biotech

B.Braun

Beijing Taikesiman

Beijing Datsing Bio-tech

Baxter

Zhonghui Shengxi

Saikesaisi Holdings Group

Meril Life Sciences

GELITA MEDICAL

Foryou Medical

Curasan AG

Cura Medical

Biotemed

BD

Absorbable Hemostatic Materials Segment by Type

Absorbable Hemostat Powder

Absorbable Hemostat Gauze

Absorbable Hemostat Gelatin Sponge

Others

Absorbable Hemostatic Materials Segment by Application

Hospitals

Clinics

Others

Absorbable Hemostatic Materials Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Absorbable Hemostatic Materials status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Absorbable Hemostatic Materials key companies, revenue, market share, and recent developments.

3. To split the Absorbable Hemostatic Materials breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Absorbable Hemostatic Materials market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Absorbable Hemostatic Materials significant trends, drivers, influence factors in global and regions.

6. To analyze Absorbable Hemostatic Materials competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Absorbable Hemostatic Materials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Absorbable Hemostatic Materials and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Absorbable Hemostatic Materials.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Absorbable Hemostatic Materials industry.

Chapter 3: Detailed analysis of Absorbable Hemostatic Materials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Absorbable Hemostatic Materials in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Absorbable Hemostatic Materials in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Absorbable Hemostatic Materials Industry Trends Table 2. Absorbable Hemostatic Materials Industry Drivers Table 3. Absorbable Hemostatic Materials Industry Opportunities and Challenges Table 4. Absorbable Hemostatic Materials Industry Restraints Table 5. Global Absorbable Hemostatic Materials Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Absorbable Hemostatic Materials Revenue Share by Company (2021-2026) Table 7. Global Absorbable Hemostatic Materials Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Absorbable Hemostatic Materials Key Company Manufacturing Base & Headquarters Table 9. Global Absorbable Hemostatic Materials Company, Product Type & Application Table 10. Global Absorbable Hemostatic Materials Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Absorbable Hemostatic Materials by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Absorbable Hemostat Powder Table 15. Significant Companies of Absorbable Hemostat Gauze Table 16. Significant Companies of Absorbable Hemostat Gelatin Sponge Table 17. Significant Companies of Others Table 18. Global Absorbable Hemostatic Materials Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Absorbable Hemostatic Materials Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Absorbable Hemostatic Materials Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Absorbable Hemostatic Materials Sales Value Share by Type (2021-2026) Table 22. Global Absorbable Hemostatic Materials Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospitals Table 24. Significant Companies of Clinics Table 25. Significant Companies of Others Table 26. Global Absorbable Hemostatic Materials Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Absorbable Hemostatic Materials Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Absorbable Hemostatic Materials Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Absorbable Hemostatic Materials Sales Value Share by Application (2021-2026) Table 30. Global Absorbable Hemostatic Materials Sales Value Share by Application (2027-2032) Table 31. Global Absorbable Hemostatic Materials Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Absorbable Hemostatic Materials Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Absorbable Hemostatic Materials Sales Value Share by Region (2021-2026) Table 34. Global Absorbable Hemostatic Materials Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Absorbable Hemostatic Materials Sales Value Share by Region (2027-2032) Table 36. Global Absorbable Hemostatic Materials Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Absorbable Hemostatic Materials Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Absorbable Hemostatic Materials Sales Value Market Share by Country (2021-2026) Table 39. Global Absorbable Hemostatic Materials Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Absorbable Hemostatic Materials Sales Value Market Share by Country (2027-2032) Table 41. Johnson & Johnson Company Information Table 42. Johnson & Johnson Business Overview Table 43. Johnson & Johnson Absorbable Hemostatic Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Johnson & Johnson Absorbable Hemostatic Materials Product Portfolio Table 45. Johnson & Johnson Recent Development Table 46. Guizhou Jin Jiu Biotech Company Information Table 47. Guizhou Jin Jiu Biotech Business Overview Table 48. Guizhou Jin Jiu Biotech Absorbable Hemostatic Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Guizhou Jin Jiu Biotech Absorbable Hemostatic Materials Product Portfolio Table 50. Guizhou Jin Jiu Biotech Recent Development Table 51. B.Braun Company Information Table 52. B.Braun Business Overview Table 53. B.Braun Absorbable Hemostatic Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. B.Braun Absorbable Hemostatic Materials Product Portfolio Table 55. B.Braun Recent Development Table 56. Beijing Taikesiman Company Information Table 57. Beijing Taikesiman Business Overview Table 58. Beijing Taikesiman Absorbable Hemostatic Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Beijing Taikesiman Absorbable Hemostatic Materials Product Portfolio Table 60. Beijing Taikesiman Recent Development Table 61. Beijing Datsing Bio-tech Company Information Table 62. Beijing Datsing Bio-tech Business Overview Table 63. Beijing Datsing Bio-tech Absorbable Hemostatic Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Beijing Datsing Bio-tech Absorbable Hemostatic Materials Product Portfolio Table 65. Beijing Datsing Bio-tech Recent Development Table 66. Baxter Company Information Table 67. Baxter Business Overview Table 68. Baxter Absorbable Hemostatic Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Baxter Absorbable Hemostatic Materials Product Portfolio Table 70. Baxter Recent Development Table 71. Zhonghui Shengxi Company Information Table 72. Zhonghui Shengxi Business Overview Table 73. Zhonghui Shengxi Absorbable Hemostatic Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Zhonghui Shengxi Absorbable Hemostatic Materials Product Portfolio Table 75. Zhonghui Shengxi Recent Development Table 76. Saikesaisi Holdings Group Company Information Table 77. Saikesaisi Holdings Group Business Overview Table 78. Saikesaisi Holdings Group Absorbable Hemostatic Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Saikesaisi Holdings Group Absorbable Hemostatic Materials Product Portfolio Table 80. Saikesaisi Holdings Group Recent Development Table 81. Meril Life Sciences Company Information Table 82. Meril Life Sciences Business Overview Table 83. Meril Life Sciences Absorbable Hemostatic Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Meril Life Sciences Absorbable Hemostatic Materials Product Portfolio Table 85. Meril Life Sciences Recent Development Table 86. GELITA MEDICAL Company Information Table 87. GELITA MEDICAL Business Overview Table 88. GELITA MEDICAL Absorbable Hemostatic Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. GELITA MEDICAL Absorbable Hemostatic Materials Product Portfolio Table 90. GELITA MEDICAL Recent Development Table 91. Foryou Medical Company Information Table 92. Foryou Medical Business Overview Table 93. Foryou Medical Absorbable Hemostatic Materials Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Foryou Medical Absorbable Hemostatic Materials Product Portfolio Table 95. Foryou Medical Recent Development Table 96. Curasan AG Company Information Table 97. Curasan AG Business Overview Table 98. Curasan AG Absorbable Hemostatic Materials Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Curasan AG Absorbable Hemostatic Materials Product Portfolio Table 100. Curasan AG Recent Development Table 101. Cura Medical Company Information Table 102. Cura Medical Business Overview Table 103. Cura Medical Absorbable Hemostatic Materials Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Cura Medical Absorbable Hemostatic Materials Product Portfolio Table 105. Cura Medical Recent Development Table 106. Biotemed Company Information Table 107. Biotemed Business Overview Table 108. Biotemed Absorbable Hemostatic Materials Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Biotemed Absorbable Hemostatic Materials Product Portfolio Table 110. Biotemed Recent Development Table 111. BD Company Information Table 112. BD Business Overview Table 113. BD Absorbable Hemostatic Materials Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. BD Absorbable Hemostatic Materials Product Portfolio Table 115. BD Recent Development Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Absorbable Hemostatic Materials Product Image Figure 2. Global Absorbable Hemostatic Materials Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Absorbable Hemostatic Materials Market Size (2021-2032) & (US$ Million) Figure 4. Global Absorbable Hemostatic Materials Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Absorbable Hemostat Powder Image Figure 8. Absorbable Hemostat Gauze Image Figure 9. Absorbable Hemostat Gelatin Sponge Image Figure 10. Others Image Figure 11. Global Absorbable Hemostatic Materials Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Absorbable Hemostatic Materials Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Absorbable Hemostatic Materials Sales Value Share by Type (2021-2032) Figure 14. Hospitals Image Figure 15. Clinics Image Figure 16. Others Image Figure 17. Global Absorbable Hemostatic Materials Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Absorbable Hemostatic Materials Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Absorbable Hemostatic Materials Sales Value Share by Application (2021-2032) Figure 20. Global Absorbable Hemostatic Materials Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Absorbable Hemostatic Materials Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Absorbable Hemostatic Materials Sales Value (2021-2032) & (US$ Million) Figure 23. North America Absorbable Hemostatic Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Absorbable Hemostatic Materials Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Absorbable Hemostatic Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Absorbable Hemostatic Materials Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Absorbable Hemostatic Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Absorbable Hemostatic Materials Sales Value (2021-2032) & (US$ Million) Figure 29. South America Absorbable Hemostatic Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Absorbable Hemostatic Materials Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Absorbable Hemostatic Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Absorbable Hemostat Powder
  • Absorbable Hemostat Gauze
  • Absorbable Hemostat Gelatin Sponge
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Johnson & Johnson
  • Guizhou Jin Jiu Biotech
  • B.Braun
  • Beijing Taikesiman
  • Beijing Datsing Bio-tech
  • Baxter
  • Zhonghui Shengxi
  • Saikesaisi Holdings Group
  • Meril Life Sciences
  • GELITA MEDICAL
  • Foryou Medical
  • Curasan AG
  • Cura Medical
  • Biotemed
  • BD

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Absorbable Hemostatic Materials Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Absorbable Hemostatic Materials Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Absorbable Hemostatic Materials Market Dynamics
  1. 2.1 Absorbable Hemostatic Materials Industry Trends
  2. 2.2 Absorbable Hemostatic Materials Industry Drivers
  3. 2.3 Absorbable Hemostatic Materials Industry Opportunities and Challenges
  4. 2.4 Absorbable Hemostatic Materials Industry Restraints
3 Absorbable Hemostatic Materials Market by Company
  1. 3.1 Global Absorbable Hemostatic Materials Company Revenue Ranking in 2025
  2. 3.2 Global Absorbable Hemostatic Materials Revenue by Company (2021-2026)
  3. 3.3 Global Absorbable Hemostatic Materials Company Ranking (2024-2026)
  4. 3.4 Global Absorbable Hemostatic Materials Company Manufacturing Base and Headquarters
  5. 3.5 Global Absorbable Hemostatic Materials Company Product Type and Application
  6. 3.6 Global Absorbable Hemostatic Materials Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Absorbable Hemostatic Materials Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Absorbable Hemostatic Materials Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Absorbable Hemostatic Materials Market by Type
  1. 4.1 Absorbable Hemostatic Materials Type Introduction
  2. 4.1.1 Absorbable Hemostat Powder
  3. 4.1.2 Absorbable Hemostat Gauze
  4. 4.1.3 Absorbable Hemostat Gelatin Sponge
  5. 4.1.4 Others
  6. 4.2 Global Absorbable Hemostatic Materials Sales Value by Type
  7. 4.2.1 Global Absorbable Hemostatic Materials Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Absorbable Hemostatic Materials Sales Value by Type (2021-2032)
  9. 4.2.3 Global Absorbable Hemostatic Materials Sales Value Share by Type (2021-2032)
5 Absorbable Hemostatic Materials Market by Application
  1. 5.1 Absorbable Hemostatic Materials Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Absorbable Hemostatic Materials Sales Value by Application
  6. 5.2.1 Global Absorbable Hemostatic Materials Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Absorbable Hemostatic Materials Sales Value by Application (2021-2032)
  8. 5.2.3 Global Absorbable Hemostatic Materials Sales Value Share by Application (2021-2032)
6 Absorbable Hemostatic Materials Regional Value Analysis
  1. 6.1 Global Absorbable Hemostatic Materials Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Absorbable Hemostatic Materials Sales Value by Region (2021-2032)
  3. 6.2.1 Global Absorbable Hemostatic Materials Sales Value by Region: 2021-2026
  4. 6.2.2 Global Absorbable Hemostatic Materials Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Absorbable Hemostatic Materials Sales Value (2021-2032)
  7. 6.3.2 North America Absorbable Hemostatic Materials Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Absorbable Hemostatic Materials Sales Value (2021-2032)
  10. 6.4.2 Europe Absorbable Hemostatic Materials Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Absorbable Hemostatic Materials Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Absorbable Hemostatic Materials Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Absorbable Hemostatic Materials Sales Value (2021-2032)
  16. 6.6.2 South America Absorbable Hemostatic Materials Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Absorbable Hemostatic Materials Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Absorbable Hemostatic Materials Sales Value Share by Country, 2025 VS 2032
7 Absorbable Hemostatic Materials Country-level Value Analysis
  1. 7.1 Global Absorbable Hemostatic Materials Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Absorbable Hemostatic Materials Sales Value by Country (2021-2032)
  3. 7.2.1 Global Absorbable Hemostatic Materials Sales Value by Country (2021-2026)
  4. 7.2.2 Global Absorbable Hemostatic Materials Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Absorbable Hemostatic Materials Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Absorbable Hemostatic Materials Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Absorbable Hemostatic Materials Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Absorbable Hemostatic Materials Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Guizhou Jin Jiu Biotech
  8. 8.2.1 Guizhou Jin Jiu Biotech Company Information
  9. 8.2.2 Guizhou Jin Jiu Biotech Business Overview
  10. 8.2.3 Guizhou Jin Jiu Biotech Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Guizhou Jin Jiu Biotech Absorbable Hemostatic Materials Product Portfolio
  12. 8.2.5 Guizhou Jin Jiu Biotech Recent Developments
  13. 8.3 B.Braun
  14. 8.3.1 B.Braun Company Information
  15. 8.3.2 B.Braun Business Overview
  16. 8.3.3 B.Braun Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  17. 8.3.4 B.Braun Absorbable Hemostatic Materials Product Portfolio
  18. 8.3.5 B.Braun Recent Developments
  19. 8.4 Beijing Taikesiman
  20. 8.4.1 Beijing Taikesiman Company Information
  21. 8.4.2 Beijing Taikesiman Business Overview
  22. 8.4.3 Beijing Taikesiman Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Beijing Taikesiman Absorbable Hemostatic Materials Product Portfolio
  24. 8.4.5 Beijing Taikesiman Recent Developments
  25. 8.5 Beijing Datsing Bio-tech
  26. 8.5.1 Beijing Datsing Bio-tech Company Information
  27. 8.5.2 Beijing Datsing Bio-tech Business Overview
  28. 8.5.3 Beijing Datsing Bio-tech Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Beijing Datsing Bio-tech Absorbable Hemostatic Materials Product Portfolio
  30. 8.5.5 Beijing Datsing Bio-tech Recent Developments
  31. 8.6 Baxter
  32. 8.6.1 Baxter Company Information
  33. 8.6.2 Baxter Business Overview
  34. 8.6.3 Baxter Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Baxter Absorbable Hemostatic Materials Product Portfolio
  36. 8.6.5 Baxter Recent Developments
  37. 8.7 Zhonghui Shengxi
  38. 8.7.1 Zhonghui Shengxi Company Information
  39. 8.7.2 Zhonghui Shengxi Business Overview
  40. 8.7.3 Zhonghui Shengxi Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Zhonghui Shengxi Absorbable Hemostatic Materials Product Portfolio
  42. 8.7.5 Zhonghui Shengxi Recent Developments
  43. 8.8 Saikesaisi Holdings Group
  44. 8.8.1 Saikesaisi Holdings Group Company Information
  45. 8.8.2 Saikesaisi Holdings Group Business Overview
  46. 8.8.3 Saikesaisi Holdings Group Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Saikesaisi Holdings Group Absorbable Hemostatic Materials Product Portfolio
  48. 8.8.5 Saikesaisi Holdings Group Recent Developments
  49. 8.9 Meril Life Sciences
  50. 8.9.1 Meril Life Sciences Company Information
  51. 8.9.2 Meril Life Sciences Business Overview
  52. 8.9.3 Meril Life Sciences Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Meril Life Sciences Absorbable Hemostatic Materials Product Portfolio
  54. 8.9.5 Meril Life Sciences Recent Developments
  55. 8.10 GELITA MEDICAL
  56. 8.10.1 GELITA MEDICAL Company Information
  57. 8.10.2 GELITA MEDICAL Business Overview
  58. 8.10.3 GELITA MEDICAL Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GELITA MEDICAL Absorbable Hemostatic Materials Product Portfolio
  60. 8.10.5 GELITA MEDICAL Recent Developments
  61. 8.11 Foryou Medical
  62. 8.11.1 Foryou Medical Company Information
  63. 8.11.2 Foryou Medical Business Overview
  64. 8.11.3 Foryou Medical Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Foryou Medical Absorbable Hemostatic Materials Product Portfolio
  66. 8.11.5 Foryou Medical Recent Developments
  67. 8.12 Curasan AG
  68. 8.12.1 Curasan AG Company Information
  69. 8.12.2 Curasan AG Business Overview
  70. 8.12.3 Curasan AG Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Curasan AG Absorbable Hemostatic Materials Product Portfolio
  72. 8.12.5 Curasan AG Recent Developments
  73. 8.13 Cura Medical
  74. 8.13.1 Cura Medical Company Information
  75. 8.13.2 Cura Medical Business Overview
  76. 8.13.3 Cura Medical Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cura Medical Absorbable Hemostatic Materials Product Portfolio
  78. 8.13.5 Cura Medical Recent Developments
  79. 8.14 Biotemed
  80. 8.14.1 Biotemed Company Information
  81. 8.14.2 Biotemed Business Overview
  82. 8.14.3 Biotemed Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Biotemed Absorbable Hemostatic Materials Product Portfolio
  84. 8.14.5 Biotemed Recent Developments
  85. 8.15 BD
  86. 8.15.1 BD Company Information
  87. 8.15.2 BD Business Overview
  88. 8.15.3 BD Absorbable Hemostatic Materials Revenue and Gross Margin (2021-2026)
  89. 8.15.4 BD Absorbable Hemostatic Materials Product Portfolio
  90. 8.15.5 BD Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst